These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28687937)

  • 21. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial.
    Verhoeven V; Van der Auwera A; Van Gaal L; Remmen R; Apers S; Stalpaert M; Wens J; Hermans N
    BMC Complement Altern Med; 2015 Mar; 15():52. PubMed ID: 25879228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol
    Domenech M; Casas R; Ruiz-León AM; Sobrino J; Ros E; Estruch R
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.
    Becker DJ; French B; Morris PB; Silvent E; Gordon RY
    Am Heart J; 2013 Jul; 166(1):187-96. PubMed ID: 23816039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia.
    Kasliwal RR; Bansal M; Gupta R; Shah S; Dani S; Oomman A; Pai V; Prasad GM; Singhvi S; Patel J; Sivam S; Trehan N
    Nutrition; 2016; 32(7-8):767-76. PubMed ID: 27143594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
    Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
    Bianconi V; Mannarino MR; Sahebkar A; Cosentino T; Pirro M
    Curr Cardiol Rep; 2018 May; 20(7):53. PubMed ID: 29802549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
    Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial.
    Ottestad I; Ose L; Wennersberg MH; Granlund L; Kirkhus B; Retterstøl K
    Atherosclerosis; 2013 Jun; 228(2):421-5. PubMed ID: 23623012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease.
    Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS
    Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study.
    Spigoni V; Aldigeri R; Antonini M; Micheli MM; Fantuzzi F; Fratter A; Pellizzato M; Derlindati E; Zavaroni I; Bonadonna RC; Dei Cas A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.
    Cicero AFG; Fogacci F; Morbini M; Colletti A; Bove M; Veronesi M; Giovannini M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):283-288. PubMed ID: 28537012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
    JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
    Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
    Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study.
    Blom DJ; Djedjos CS; Monsalvo ML; Bridges I; Wasserman SM; Scott R; Roth E
    Circ Res; 2015 Sep; 117(8):731-41. PubMed ID: 26228031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.